David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHS
1601
DELISTED
Chicos FAS, Inc.
CHS
| $4.3M | 0.01% |
1,008,319
+522,672
| +108% | +$2.9M |
|
1602
CALL
Ecolab
ECL
$81.5B
| $4.29M | 0.01% |
+24,300
| New | +$3.95M |
|
1603
CALL
Royal Caribbean
RCL
$77.6B
| $4.29M | 0.01% |
37,400
+11,800
| +46% | +$1.34M |
|
1604
PUT
Microchip Technology
MCHP
$40.2B
| $4.27M | 0.01% |
103,000
-3,000
| -3% | -$124K |
|
1605
e.l.f. Beauty
ELF
$6.31B
| $4.26M | 0.01% |
402,081
+249,458
| +163% | +$2.22M |
|
1606
Helen of Troy
HELE
$679M
| $4.26M | 0.01% |
+36,742
| New | +$4.24M |
|
|
CNACU
1607
DELISTED
Constellation Alpha Capital Corp. Unit
CNACU
| $4.24M | 0.01% |
450,000
| – | – |
|
|
COHR
1608
CALL
DELISTED
Coherent Inc
COHR
| $4.24M | 0.01% |
29,900
+3,200
| +12% | +$405K |
|
1609
CALL
Marriott Vacations Worldwide
VAC
$3.95B
| $4.24M | 0.01% |
45,300
+824
| +2% | +$74K |
|
1610
Enel Chile
ENIC
$6.18B
| $4.23M | 0.01% |
816,817
+29,957
| +4% | +$156K |
|
|
CJ
1611
DELISTED
C&J Energy Services, Inc.
CJ
| $4.22M | 0.01% |
271,655
+151,000
| +125% | +$2.44M |
|
|
Y
1612
DELISTED
Alleghany Corp
Y
| $4.2M | 0.01% |
6,862
+1,470
| +27% | +$919K |
|
1613
Jacobs Solutions
J
$17.7B
| $4.19M | 0.01% |
67,396
-231,594
| -77% | -$13M |
|
|
EXPR
1614
DELISTED
Express, Inc.
EXPR
| $4.18M | 0.01% |
48,835
-20,052
| -29% | -$2.02M |
|
1615
Insteel Industries
IIIN
$591M
| $4.18M | 0.01% |
199,764
+158,600
| +385% | +$3.49M |
|
1616
Coherus Oncology
CHRS
$224M
| $4.18M | 0.01% |
306,274
-71,899
| -19% | -$959K |
|
1617
8x8 Inc
EGHT
$274M
| $4.17M | 0.01% |
206,655
-292,660
| -59% | -$5.72M |
|
1618
PUT
Bath & Body Works
BBWI
$3.81B
| $4.17M | 0.01% |
187,158
-163,284
| -47% | -$3.59M |
|
1619
Terreno Realty
TRNO
$7.36B
| $4.17M | 0.01% |
99,213
-13,995
| -12% | -$559K |
|
|
THCBU
1620
DELISTED
Tuscan Holdings Corp. Unit
THCBU
| $4.17M | 0.01% |
+400,000
| New | +$4.08M |
|
|
CSLT
1621
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $4.17M | 0.01% |
1,111,311
+497,605
| +81% | +$1.58M |
|
1622
MidCap Financial Investment
MFIC
$794M
| $4.16M | 0.01% |
274,596
+29,741
| +12% | +$446K |
|
1623
PUT
Owens Corning
OC
$11.5B
| $4.16M | 0.01% |
88,200
+3,100
| +4% | +$152K |
|
1624
PUT
Lumen
LUMN
$6.28B
| $4.14M | 0.01% |
345,000
-160,000
| -32% | -$2.22M |
|
|
AUY
1625
DELISTED
Yamana Gold, Inc.
AUY
| $4.13M | 0.01% |
1,585,275
+1,134,277
| +252% | +$2.94M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.